Skip to main content

Table 3 Duration of treatment

From: Phase I study of intermittent and chronomodulated oral therapy with capecitabine in patients with advanced and/or metastatic cancer

Dose level [mg/mq/die] No cycles administered [1 cycle = 21 days] No. of patients No. cycles per patient median [range]
1500 21 3 5 [2–14]
1750 33 3 10 [4–19]
2000 24 3 3 [2–19]
2250 24 3 8 [5–11]
2500 28 6 7 [2–10]
2750 49 9 5 [2–12]